In low dimensional cuprates several interesting phenomena, including high Tc superconductivity, are deeply connected to electron correlations on Cu and the presence of the Zhang-Rice (ZR) singlet ...state. Here, we report on direct spectroscopic observation of the ZR state responsible for the low-energy physical properties in two isostructural A-site ordered cuprate perovskites, CaCu(3)Co(4)O(12) and CaCu(3)Cr(4)O(12) as revealed by resonant soft x-ray absorption spectroscopy on the Cu L(3,2)- and O K-edges. These measurements reveal the signature of Cu in the high-energy 3+ (3d(8)), the typical 2+ (3d(9)), as well as features of the ZR singlet state (i.e., 3d(9)L, L denotes an oxygen hole). First principles GGA + U calculations affirm that the B-site cation controls the degree of Cu-O hybridization and, thus, the Cu valency. These findings introduce another avenue for the study and manipulation of cuprates, bypassing the complexities inherent to conventional chemical doping (i.e. disorder) that hinder the relevant physics.
Aldosterone/renin ratio (ARR) is currently regarded as the most reliable and available screening test for primary aldosteronism (PA), however, the falling accuracy of ARR with increasing age has ...posed crucial challenge for PA screening among older-aged population. To clarify potential effects of age on screening for PA, 216 subjects with PA and 657 subjects with non-PA were recruited and subdivided into four age groups (⩽39, 40-49, 50-59 and ⩾60 years) and their biochemical parameters were compared. As expected, plasma renin activity (PRA) lowered more than plasma aldosterone concentration (PAC) and led to gradually elevated ARR with increasing age in the non-PA group (P<0.001), whereas this phenomenon was unconspicuous in the PA group. The best cut-off values of ARR for PA screening were elevated in subjects ⩾50 years, whereas the area under the receiver operating characteristic curves (AUCs), sensitivity, specificity and Youden's index (YI) of ARR were declined with increasing age, especially in patients ⩾60 years (AUC=0.863, sensitivity=95.2%, specificity=69.0%, YI=0.643). The AUCs of PAC increased with increasing age and even slightly surpassed that of ARR in patients ⩾60 years (AUCPAC=0.884). Our data suggest that the criteria of ARR for PA screening in patients ⩾50 years may need setting higher; the falling accuracy of ARR with increasing age, especially in patients ⩾60 years, could be improved by taking into account the absolute value of the PAC when applicable by the center.
•Sputtering-derived Hf1−xTixO2 gate dielectrics have been deposited on Si substrates.•Increase in crystallization temperature and reduction in Eg have been observed.•Formation of silicate layer for ...9% TiO2-doped HfO2/Si sample has been detected.
TiO2-doped HfO2 gate dielectric thin films have been deposited on Si(100) substrates by RF sputtering. The component, morphology, structure, optical and interfacial properties of Hf1−xTixO2 films related to TiO2 concentration are systematically investigated by atomic force microscope (AFM), X-ray diffraction (XRD), spectroscopic ellipsometry (SE), X-ray photoelectron spectroscopy (XPS), and Fourier transformation infrared (FTIR). By employing Cauchy–Urbach model, the optical constants, such as refractive index (n), extinction coefficient (k), absorption coefficient (α), and optical band gap (Eg) have been determined precisely. Measurements from XRD have confirmed that TiO2 incorporating into HfO2 films leads to the increase of the crystallization temperature of HfO2 films with increasing the TiO2 concentration. SE analyses have indicated that reduction in band gap and refractive index has been observed with increasing the TiO2 component in Hf1−xTixO2 films. The increase in Urbach parameter EU with the increase of TiO2 concentration also suggests the rise in disorder for Hf1−xTixO2 films. FTIR measurements for Hf1−xTixO2/Si gate stack indicate the existence of the interfacial layer regardless of the TiO2 concentration. For the 9% TiO2-doped HfO2 samples, the shift in FTIR characteristic peak suggests the formation of the silicate layer, which leads to the suppressed interfacial layer growth during deposition. As a result, it can be conclude that the TiO2 component in Hf1−xTixO2 films should be controlled precisely to guarantee interfacial properties of Hf1−xTixO2/Si gate stacks.
Biodegradable chelators (BCs) are promising substitutes for conventional washing agents in the remediation of heavy metal contaminated soil with strong complexing ability and less cost. However, ...great challenges for the applications of BC–assisted washing still exist, such as the assessment of the factor affecting the efficiency of metal removal and the unclear of the metal removal mechanism. Batch washing was therefore explored to evaluate the potential for four BCs for removing Cd, Pb, and Zn from polluted soils. The soil spectroscopic characteristics before and after washing were also investigated. The results demonstrated that iminodisuccinic acid (ISA) and glutamate–N, N–diacetic acid (GLDA) were an appealing alternative to commonly used non–biodegradable ethylenediaminetetraacetic acid, but glucomonocarbonic acid (GCA) and polyaspartic acid (PASP) were less efficient. Optimal parameters of BCs were determined to be a concentration of 50 mmol L−1, a pH of 5.0, a contact time of 120 min, and a solid/liquid ratio of 1:5, considering metal removal efficiencies and the suitable cost. A single removal washing could be up to 52.39% of Cd, 71.79% of Pb, and 34.13% of Zn from mine soil, and 98.28% of Cd, 91.10% of Pb, and 90.91% of Zn from polluted farmland soil. After washing, the intensity of heavy metal binding to soil colloids increased while the metal mobility reduced because of weakly bound fractions removed by BCs. The BCs–induced soil washing revealed that the possible mechanisms of metal removal included the acid dissolution, ion exchange, and surface complexation. Our findings highlight the potential application of especially ISA and GLDA as efficient washing agents to remove potentially toxic elements from contaminated soils.
•Metal removal efficiency with different biodegradable chelator washing was studied.•The mobility of residual metals in chelator-washed soil was lower than unwashed soil.•The ISA and GLDA more effectively remove Cd, Pb, and Zn than that of GCA and PASP.•Metal removal mechanism dominated by dissolution, ion exchange, and complexation”.
Two new phosphorescent iridium(III) cyclometalated complexes, Ir(DPA‐Flpy)3 (1) and Ir(DPA‐Flpy)2(acac) (2) ((DPA‐Flpy)H = (9,9‐diethyl‐7‐pyridinylfluoren‐2‐yl)diphenylamine, Hacac = acetylacetone), ...have been synthesized and characterized. The incorporation of electron‐donating diphenylamino groups to the fluorene skeleton is found to increase the highest occupied molecular orbital (HOMO) levels and add hole‐transporting ability to the phosphorescent center. Both complexes are highly amorphous and morphologically stable solids and undergo glass transitions at 160 and 153 °C, respectively. These iridium phosphors emit bright yellow to orange light at room temperature with relatively short lifetimes (< 1 μs) in both solution and the solid state. Organic light‐emitting diodes (OLEDs) fabricated using 1 and 2 as phosphorescent dopant emitters constructed with a multilayer configuration show very high efficiencies. The homoleptic iridium complex 1 is shown to be a more efficient electrophosphor than the heteroleptic congener 2. Efficient electrophosphorescence with a maximum external quantum efficiency close to 10 % ph/el (photons per electron), corresponding to a luminance efficiency of ∼ 30 cd A–1 and a power efficiency of ∼ 21 lm W–1, is obtained by using 5 wt.‐% 1 as the guest dopant.
New homoleptic and heteroleptic cyclometalated iridium complexes of (9,9‐diethyl‐7‐pyridinylfluoren‐2‐yl)diphenylamine (see figure) are shown to be amorphous solids with high glass‐transition temperatures. Organic LEDs fabricated using these iridium‐based phosphors as dopant emitters and constructed with a multilayer configuration show very high efficiencies.
Summary
Background
Tildrakizumab is a high‐affinity, humanized, IgG1/κ, anti‐interleukin (IL)‐23p19 monoclonal antibody that does not bind human IL‐12 or p40 is being developed for the treatment of ...chronic plaque psoriasis.
Objectives
To evaluate the safety and efficacy of subcutaneous tildrakizumab in patients with moderate‐to‐severe chronic plaque psoriasis.
Methods
A three‐part, randomized, double‐blind, phase IIb trial was conducted in 355 adults with chronic plaque psoriasis. Participants were randomized to receive subcutaneous tildrakizumab (5, 25, 100, 200 mg) or placebo at weeks 0 and 4 (part I) and every 12 weeks thereafter until week 52 (part II). Study drug was discontinued at week 52 and participants were followed through week 72 (part III). Primary efficacy end point was Psoriasis Area and Severity Index (PASI) 75 response at week 16. Adverse events (AEs) and vital signs were monitored throughout the study.
Results
At week 16, PASI 75 responses were 33·3% (n = 14), 64·4% (n = 58), 66·3% (n = 59), 74·4% (n = 64) and 4·4% (n = 2) in the 5‐, 25‐, 100‐ and 200‐mg tildrakizumab and placebo groups, respectively (P ≤ 0·001 for each tildrakizumab dose vs. placebo). PASI 75 response was generally maintained through week 52; only eight of 222 participants who achieved PASI 75 response at week 52 and continued to part III relapsed following discontinuation up to week 72. Possible drug‐related serious AEs included bacterial arthritis and lymphoedema (part I), and melanoma, stroke, epiglottitis and knee infection (part II).
Conclusions
Tildrakizumab had treatment effects that were superior to placebo, maintained for 52 weeks of treatment, and persisted for 20 weeks after cessation. Tildrakizumab was generally safe and well tolerated. These results suggest that IL‐23p19 is a key target for suppressing psoriasis.
What's already known about this topic?
Immune mechanism‐specific targeted biological treatments have successfully demonstrated improvements in clinical outcomes in patients with chronic plaque psoriasis.
Selective interleukin (IL)‐23 inhibition has been a recent target for novel therapies and small initial phase I trials have confirmed safety and preliminary efficacy in humans.
What does this study add?
This is the first large‐scale phase II trial to evaluate a monoclonal antibody that selectively inhibits IL‐23 in patients with chronic plaque psoriasis
.
Linked Comment: Strober, Br J Dermatol 2015; 173: 887–888.
High-k turbulence (1 < kθρs < 5) spectrograms have been directly measured in density modulation experiments of the EAST tokamak using the collective Thomson scattering diagnostic system. ...Density-peaking modulation is achieved in Lower Hybrid Wave (LHW) modulation experiments, revealing that the broadband turbulence is sensitive to the power modulation of LHW and the concomitant variation of density-peaking. Additionally, the contributions of 2.45/4.6 GHz LHW to density peaking differ when Neutral Beam Injection (NBI) is on/off, displaying distinct responses of broadband turbulence in low/high frequency ranges. It is found by cross-coherence analysis that the phase angle is negative in cases without NBI, while in NBI cases it can be modulated from negative to positive, indicating a significant transition of radial turbulence propagation. These findings highlight the active control of density-peaking via auxiliary heating in tokamak plasmas and suggest the potential role of high-k turbulence in density-peaking modulation.
PDF
